How Effective is Nivolumab in Gynecologic Cancers?
Clinical studies have shown variable efficacy of nivolumab in gynecologic cancers. In ovarian cancer, nivolumab has demonstrated some promise, particularly in patients who have relapsed or are resistant to other treatments. For endometrial cancer, nivolumab has been studied both as a monotherapy and in combination with other drugs, showing encouraging results in terms of progression-free survival. Cervical cancer, especially advanced cases, has also shown positive responses to nivolumab, with improved overall survival rates in some instances.
